Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
5Y CAGR+87.3%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
+87.3%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
23x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.74M | -38.3% |
| 2024 | $25.50M | +286.2% |
| 2023 | $6.60M | +164.1% |
| 2022 | $-10.29M | -120.5% |
| 2021 | $50.15M | +7242.9% |
| 2020 | $683000.00 | +41.7% |
| 2019 | $482000.00 | +35.8% |
| 2018 | $355000.00 | - |